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Abstract
Background  and  objectives: Tramadol  is  known  as  a  central  acting  analgesic  drug,  used  for  the
treatment of  moderate  to  severe  pain.  Local  analgesic  effect  has  been  demonstrated,  in  part
due to  local  anesthetic-like  effect,  but  other  mechanisms  remain  unclear.  The  role  of  peripheral
opioid receptors  in  the  local  analgesic  effect  is  not  known.  In  this  study,  we  examined  role  of
peripheral  opioid  receptors  in  the  local  analgesic  effect  of  tramadol  in  the  plantar  incision
model.
Methods: Young  male  Wistar  rats  were  divided  into  seven  groups:  control,  intraplantar
tramadol,  intravenous  tramadol,  intravenous  naloxone-intraplantar  tramadol,  intraplantar
naloxone-intraplantar  tramadol,  intravenous  naloxone-intravenous  tramadol,  and  intravenous
naloxone.  After  receiving  the  assigned  drugs  (tramadol  5  mg,  naloxone  200  g  or  0.9%  NaCl),
rats were  submitted  to  plantar  incision,  and  withdrawal  thresholds  after  mechanical  stimuli
with von  Frey  ﬁlaments  were  assessed  at  baseline,  10,  15,  30,  45  and  60  min  after  incision.
Results: Plantar  incision  led  to  marked  mechanical  hyperalgesia  during  the  whole  period
of observation  in  the  control  group,  no  mechanical  hyperalgesia  were  observed  in  intra-
plantar tramadol  group,  intraplantar  naloxone-intraplantar  tramadol  group  and  intravenous
naloxone-intraplantar  tramadol.  In  the  intravenous  tramadol  group  a  late  increase  in  with-
drawal thresholds  (after  45  min)  was  observed,  the  intravenous  naloxone-intravenous  tramadol
group and  intravenous  naloxone  remained  hyperalgesic  during  the  whole  period.
Conclusions:  Tramadol  presented  an  early  local  analgesic  effect  decreasing  mechanical  hyper-
algesia induced  by  plantar  incision.  This  analgesic  effect  was  not  mediated  by  peripheral  opioid
receptors.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.∗ Corresponding author.
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O  efeito  analgésico  de  tramadol  não  é  mediado  por  receptores  opioides  na  dor  de
ratos  no  pós-operatório  imediato
Resumo
Justiﬁcativa  e  objetivos:  Tramadol  é  conhecido  como  um  fármaco  analgésico  de  ac¸ão  central,
usado para  o  tratamento  de  dor  moderada  a  grave.  O  efeito  analgésico  local  foi  demonstrado,
em parte  devido  ao  efeito  semelhante  ao  anestésico  local,  mas  outros  mecanismos  permanecem
obscuros. O  papel  dos  receptores  opioides  periféricos  no  efeito  analgésico  local  não  é  conhecido.
Neste estudo,  examinamos  o  papel  dos  receptores  opioides  periféricos  no  efeito  analgésico  local
de tramadol  em  modelo  de  incisão  plantar.
Métodos:  Ratos  Wistar,  jovens  e  machos,  foram  divididos  em  sete  grupos:  controle,  tramadol
intraplantar,  tramadol  intravenoso,  tramadol  intraplantar-naloxona  intravenosa,  tramadol
intraplantar-naloxona  intraplantar,  tramadol  intravenoso-naloxona  intravenosa  e  naloxona
intravenosa.  Após  receberem  os  medicamentos  designados  (5  mg  de  tramadol,  200  mg  de  nalox-
ona ou  NaCl  a  0,9%,  os  ratos  foram  submetidos  à  incisão  plantar,  e  os  limiares  de  retirada  após
estímulos mecânicos  com  ﬁlamentos  de  von  Frey  foram  avaliados  no  início  do  estudo  e  nos
minutos 10,  15,  30,  45  e  60  após  a  incisão.
Resultados:  A  incisão  plantar  levou  à  hiperalgesia  mecânica  acentuada  durante  todo  o  período
de observac¸ão  no  grupo  controle;  hiperalgesia  mecânica  não  foi  observada  nos  grupos  tramadol
intraplantar,  tramadol  intraplantar-naloxona  intraplantar  e  tramadol  intraplantar-naloxona
intravenosa.  No  grupo  tramadol  intravenoso,  um  aumento  tardio  do  limiar  de  retirada  (após
45 minutos)  foi  observado,  os  grupos  tramadol  intravenoso-naloxona  intravenosa  e  naloxona
intravenosa  permaneceram  hiperalgésicos  durante  todo  o  período.
Conclusões:  Tramadol  apresentou  efeito  analgésico  local  inicial,  diminuindo  a  hiperalgesia
mecânica  induzida  pela  incisão  plantar.  Esse  efeito  analgésico  não  foi  mediado  por  receptores
opioides  periféricos.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
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Introduction
Tramadol,  (1-RS,2RS)-2-[(dimethyl-amino)-methyl]-1-(3-
methoxyphenyl)-cyclohexanol  hydrochloride,  is  an  analgesic
drug  used  mainly  for  treatment  of  moderate  to  severe,  as
well  as  acute  and  chronic  pain.1,2 It  presents  a  weak  opioid
effect  and  has  other  different  mechanism  of  action  through
the  decrease  of  the  reuptake  of  monoaminergic  neuro-
transmitters  (5-hydroxy-tryptamine  and  noradrenaline).3
Additionally  it  presents  an  analgesic  effect  in  peripheral
nerves,  which  is,  in  part,  local  anesthetic-like.4--6
The  peripheral  analgesic  effect  of  tramadol  has  been  also
showed  in  humans  after  inﬁltration  for  third  molar  extrac-
tion,  minor  surgical  procedures  in  children  and  as  adjuvant
to  local  anesthetics  to  reduce  postoperative  pain.7--12 Periph-
eral  opioid  receptors  have  long  been  described  and  their  role
in  analgesia  in  animals  and  humans  demonstrated,13--20 but
little  is  known  about  peripheral  opioid  mediated  effect  of
tramadol.
This  study  aimed  to  evaluate  the  role  of  opioid  receptors
in  the  analgesic  effects  of  intraplantar  tramadol  in  a  model
of  postoperative  pain.
Materials and methodsAnimals
The  experiments  were  performed  after  the  approval  of
the  Bioethics  Committee  of  the  Hospital  of  Clinics  of  The
M
R
wniversity  of  São  Paulo  Faculty  of  Medicine  and  accord-
ng  to  the  Committee  for  Research  and  Ethical  Issues  of
he  IASP.21 All  experiments  were  performed  on  Wistar  male
ats,  weighing  250  g,  supplied  by  own  breeding  facilities  of
he  University  of  São  Paulo  Faculty  of  Medicine.  The  total
umber  of  animals  used  in  the  study  was  35  rats.  All  behav-
oral  experiments  were  conducted  between  9:00  am  and
2:00  pm.  All  animals  were  housed  in  pairs,  in  cages  with
edding  and  free  access  to  food  and  water.
lantar  incision
he  rat  hind  paw  plantar  incision  model  was  performed
s  previously  described.22 Brieﬂy,  rats  were  anesthetized
ith  2%  to  3%  isoﬂurane  delivered  via  nose  cone.  The  plan-
ar  aspect  of  the  right  hind  paw  was  prepared  in  a  sterile
anner  with  a  10%  povidone-iodine  solution  and  draped.  A
 cm  longitudinal  incision  was  made  with  a number  11  blade
hrough  skin  and  fascia  of  the  plantar  aspect  of  the  paw  of
he  rat,  starting  0.5  cm  from  the  proximal  edge  of  the  heel
nd  extending  toward  the  toes.  The  ﬂexor  muscle  was  ele-
ated  and  incised  longitudinally  and  the  muscle  origin  and
nsertion  remain  intact.  After  hemostasis  with  gentle  pres-
ure,  the  skin  was  opposed  with  two  simple  sutures  of  5--0
ononylon.echanical  hyperalgesia
ats  were  placed  on  an  elevated  plastic  mesh  ﬂoor  covered
ith  a  clear  plastic  cage  top.  The  animals  were  allowed  to
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experimentally  to  clinical  and  real  situations. The  devel-
opment  and  search  for  models  that  mimic  clinical  scenarios
is  very  important.  In  this  study,  we  used  the  plantar  incision
model,  a  postoperative  pain  model,  being  used  for  the  last
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Figure  1  Withdrawal  thresholds  to  mechanical  stimulus  after
intraplantar  or  intravenous  tramadol.  Withdrawal  thresholds
were higher  in  the  Ipl-tramadol  and  Ipl-naloxone  +  Ipl-
tramadol  groups,  Iv-tramadol  presented  a  late  analgesia  after88  
mbulate,  explore,  and  eventually  rest  lying  on  the  mesh.
or  testing  pain  behaviors,  calibrated  von  Frey  ﬁlaments
thin  plastic  ﬁlaments  with  calibrated  forces)  were  applied
nderneath  the  cage  adjacent  to  the  wound.  Each  ﬁla-
ent  was  applied  once  and  continuing  until  a  withdrawal
ccurred,  which  was  considered  as  the  withdrawal  thresh-
ld.  Filaments  with  bending  forces  of  5.9;  9.8;  13.7;  19.7;
9.2;  58.8;  78.4;  98  147,  255,  588  and  980  mN  were  used  in
he  study.
xperimental  design
fter  assessment  of  the  pre  incision  withdrawal  thresh-
lds  for  mechanical  hyperalgesia,  animals  were  divided
nto  seven  experimental  groups  of  ﬁve  animals  each:  1  --
ontrol,  50  L  of  0.9%  NaCl  solution  were  injected  in  the
lantar  aspect  of  the  right  hindpaw,  5  min  later  another
0  L  of  0.9%  NaCl  solution  were  reinjected;  2  --  Intraplan-
ar  tramadol  (Ipl-tramadol),  50  L  of  0.9%  NaCl  solution
ere  injected  in  the  plantar  aspect  of  the  right  hind-
aw  and  5  min  later  5  mg  (20  mg/kg)  of  tramadol  dissolved
n  50  L  of  0.9%  NaCl  were  administered  in  the  plantar
spect  of  the  right  hindpaw;  3  --  Intravenous  tramadol  (Iv-
ramadol),  50  L  of  0.9%  NaCl  solution  were  injected  in
he  plantar  aspect  of  the  right  hindpaw  and  5 min  later
 mg  of  tramadol  were  injected  in  the  dorsal  vein  of  the
enis;  4  --  Intravenous  naloxone-intraplantar  tramadol  (Iv-
aloxone  +  Ipl-tramadol),  200  g  naloxone  injected  in  the
orsal  vein  of  the  penis  5  min  before  5  mg  of  tramadol  dis-
olved  in  50  L  of  0.9%  NaCl  in  the  plantar  aspect  of  the
ight  hindpaw;  5  --  Intraplantar  naloxone-intraplantar  tra-
adol  (Ipl-naloxone  +  Ipl-tramadol),  200  g  naloxone  was
njected  in  the  right  hindpaw  5  min  before  intraplantar
ramadol;  6  --  Intravenous  naloxone-intravenous  tramadol
Iv-naloxone  +  Iv-tramadol);  200  g  naloxone  injected  in  the
orsal  vein  of  the  penis  5  min  before  5  mg  of  tramadol  dis-
olved  in  50  L  of  0.9%  NaCl  injected  in  the  dorsal  vein  of  the
enis;  7  --  Naloxone  (Iv-naloxone),  200  g  naloxone  injected
n  the  dorsal  vein  of  the  penis  and  50  L of  0.9%  NaCl  solution
njected  in  the  paw.  All  injections  were  done  under  gen-
ral  anesthesia  with  2%--3%  isoﬂurane.  Animals  were  kept
nesthetized  and  5  min  after  second  injection  they  were
ubmitted  to  plantar  incision.  As  soon  as  the  animals  recov-
red,  the  tests  were  started  and  performed  10,  15,  30,  45
nd  60  min  after  recovery  from  anesthesia.  At  the  end  of  the
xperiments  the  animals  were  submitted  to  euthanasia  with
ethal  dose  of  sodium  thiopental.
rugs
ramadol  hydrochloride  and  naloxone  hydrochloride  were
rovided  by  Cristália  Prod.  Quim.  Farm,  São  Paulo,  SP,  Brazil.
tatistical  analysis
ll  data  were  analyzed  by  Prism  5.0  software  (GraphPad
oftware,  Inc.,  USA).  Withdrawal  threshold  to  mechani-
al  stimuli  are  non-continuous  and  were  analyzed  with
onparametric  tests.  The  data  were  expressed  as  median
nd  interquartile  range.  Differences  were  determined  by
4
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ruskal--Wallis  test  followed  by  Dunn’s  post  hoc  test  for
omparing  paw  withdrawal  threshold.
esults
lantar  incision  led  to  mechanical  hyperalgesia  during  the
hole  period  of  observation.  In  the  control  group  the
edian  withdrawal  threshold  to  von  Frey  ﬁlament  decreased
rom  980  to  39  mN  after  10  min  and  98  mN  after  60  min,
n  the  intraplantar  tramadol  group  the  median  withdrawal
hreshold  was  980  mN  during  the  whole  period,  in  the  intra-
enous  tramadol  group  median  decreased  from  980  to  59  mN
fter  10  min  and  increased  after  45  min  to  255  mN  and  in
he  intraplantar  naloxone-intraplantar  tramadol  the  median
ithdrawal  threshold  was  980  mN  throughout  the  60  min  of
bservation  (Fig.  1).
In  the  intravenous  naloxone-intraplantar  tramadol  group
he  median  withdrawal  threshold  ranged  from  588  to  980  mN
hroughout  all  period  of  observation,  in  the  intravenous
aloxone-intravenous  tramadol  group,  median  went  from
80  to  59  mN,  staying  hyperalgesic  at  60  min  and  in  the  intra-
enous  naloxone,  median  went  from  980  to  20  mN  at  60  min
f  injection,  the  median  was  different  from  control  from
5  min  to  60  min  (Fig.  2).
iscussion
he  use  of  experimental  pain  models  is  under  scrutiny
ue  to  the  partial  failure  of  translation  of  results  obtained
23,245 min  of  injection.  Data  presented  as  median  ±  interquartile
nterval  (25th--75th  percentile);  p  <  0.05.  *Ipl-tramadol  and
pl-naloxone  +  Ipl-tramadol  groups  different  from  control, +Iv-
ramadol  different  from  control.
Initial  analgesia  of  local  tramadol  is  not  opioid  mediated  
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Figure  2  Withdrawal  thresholds  to  mechanical  stimulus  after
naloxone  with  or  without  tramadol.  Withdrawal  thresholds  were
higher  in  the  Iv-naloxone  +  Ipl-tramadol  group,  Iv-naloxone  +  Iv-
tramadol  was  not  different  from  control  and  withdrawal
thresholds  were  lower  in  naloxone  group  than  control  after
25 min  of  injection.  Data  presented  as  median  ±  interquartile
interval  (25th--75th  percentile);  p  <  0.05.  *Iv-naloxone  +  Ipl-
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two  decades  and  that  brings  to  the  experimental  environ-
ment  a  relevant  clinical  situation,  the  postoperative  pain.
The  prominent  clinical  characteristic  of  postoperative  pain
is  mechanical  hyperalgesia  or  mechanical  alodinia,  and  we
decided  to  observe  this  pain  modality.
Present  results  showed  an  analgesic  effect  of  intraplan-
tar  tramadol  in  the  postoperative  pain  model  used.  The
analgesic  effect  lasted  throughout  the  whole  period  of
observation  and  led  to  higher  paw  withdrawal  thresholds
than  intravenous  tramadol.  Tramadol  is  known  to  be  an
atypical  drug,  presenting  different  mechanisms  of  action
to  achieve  analgesia.  When  used  systemically,  tramadol  is
metabolized  by  cytochrome  P450  (CYP)  2D6,  and  its  major
metabolite  is  mono-o-desmethyl-tramadol  (M1),  responsi-
ble  for  the  systemic  analgesic  effect.3,25 Its  analgesic  effect
is  observed  20--40  min  after  oral  intake.26 In  the  present
study,  intravenous  tramadol  decreased  hyperalgesia  45  min
after  injection,  the  expected  time  for  tramadol  systemic
analgesia.  However,  intraplantar  tramadol  in  the  same  dose
blocked  hyperalgesia  from  the  beginning  throughout  all
observation  period.  These  results  indicate  that  the  parental
drug,  tramadol,  presents  an  early  analgesic  effect  expressed
right  after  its  injection,  effect  that  seems  to  be  local,  since
the  analgesic  effect  observed  after  intravenous  route  did  not
induce  early  analgesia.  The  observed  local  effect  seems  not
to  be  mediated  by  opioid  receptors,  no  reduction  in  anal-
gesia  was  observed  after  naloxone  neither  by  intraplantar
nor  intravenous  routes.  In  another  study  analgesic  effect  of
tramadol  in  the  same  post-operative  pain  model  was  antag-
onized  with  naloxone,  but  they  used  the  intraperitoneal  and
intrathecal  routes,  and  analgesic  effects  in  the  central  ner-
vous  system  is  due  to  the  classic  decrease  in  monoamines189
euptake  and  opioid  mediated  effects.3,26,27 Although  our
esults  did  not  ﬁnd  peripheral  opioid  action,  we  cannot  rule
ut  a  local  opioid  analgesic  effect  of  tramadol  occurring
ater.  It  has  been  demonstrated  that  there  is  an  increase
n  the  expression  of    opioid  receptor  (MOR)  synthesized
n  the  dorsal  root  ganglia,  then  trafﬁcked  to  nerve  endings
fter  intraplantar  carrageenan.28 Up  regulation  of  MOR  in
orsal  root  ganglia  was  higher  one  day  after  injection  and
ecreased  at  day  three.  Intraplantar  carrageen  an  induces
ain  behavior  that  subsides  four  hours  after  injection.  Post-
perative  pain  in  the  plantar  incision  model  peaks  at  day
ne  and  lasts  up  to  ﬁve  days,  when  thermal  and  mechani-
al  thresholds  are  similar  to  baseline.20 MOR  expression  may
ccur  later  in  this  pain  model  what  can  affect  peripheral
pioid  receptor  role.  An  interesting  data  observed  occurred
n  the  intravenous  naloxone  group,  where  thresholds  where
ower  than  in  control  group,  indicating  that  naloxone  antag-
nized  endogenous  opioids  in  the  ﬁrst  hour  after  incision,
eading  to  an  increase  in  the  pain  behavior  after  mechanical
timulus.
Local  analgesic  effect  of  tramadol  has  been  shown  to  be
imilar  to  local  anesthetic.4--6,29,30 The  mechanisms  involved
n  this  peripheral  action  are  still  not  well  understood.  Weak
nti-inﬂammatory  effect  has  been  proposed  for  tramadol
nlagesia  and  calcium  dependent  effect.31,32 Interestingly
ramadol  also  acts  as  an  agonist  of  the  transient  receptor
otential  vanilloid-1  (TRPV1)  channel,  maybe  presenting,  at
ome  extent,  a  pronociceptive  effect.33
The  results  of  this  study  indicate  that  tramadol  presents
n  early  local  analgesic  effect  decreasing  mechanical  hyper-
lgesia  induced  by  plantar  incision.  This  effect  is  not
ediated,  in  the  ﬁrst  hour,  by  peripheral  opioid  receptors.
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